Immunoivd

Medical Equipment Manufacturing, Biotechnology research and development, Research and testing · 11 Employees
Phone Number: 46840889800
Email Address: support@immunoivd.com
  • Overview
  • Employees
Access 10 Verified Employees Profiles for ImmunoivdUnlock Free Contacts Now
About
ImmunoIVD focuses on molecular assays for neonatal screening. The SPOT-it™ kit is CE marked and has been developed to facilitate population-scale screening to detect newborns with SCID, XLA and/or SMA. The company is built on a strong foundation with more than 30 years experience of successfully running a biotech company, and world renowned researchers within the field of clinical immunology and immunogenetics. Early detection increases the chances for children born with SCID, XLA and SMA to live life to its fullest. We believe all children should be given that chance.
Year Founded
2015
Social Media
LinkedinTwitter
Industry
Medical Equipment Manufacturing, Biotechnology research and development, Research and testing, IT, Internet, R&D, Genetic biotechnology consultants, Technical offices and engineering consultancies, architects, Chemistry, physics and biological engineering consultants
HQ Location
Cylindervägen 12 Nacka Strand, 131 52, SE
Keywords
Primary immunodeficiency diseasesSCIDNewborn Screeningand ImmunologyImmunology
Location
  • Cylindervägen 12 Nacka Strand, 131 52, SE

Email Formats

Sign up for free credits and discover verified email addresses of Immunoivd
FormatExamples
first + last
andywarhol@immunoivd.com
first_initial + last
awarhol@immunoivd.com
first + last_initial
andyw@immunoivd.com
first
andy@immunoivd.com
last
warhol@immunoivd.com
Get Verified Emails for 10 Immunoivd Employees

Frequently Asked Questions

Learn More about Immunoivd

Similar Companies

Medical Equipment Manufacturing, Biotechnology research and development, Research and testing

Get key business info for Immunoivd and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.